View Older Stories View More Recent Stories

Dec 20, 2023 08:00AM MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
Dec 14, 2023 09:00AM ACA Has Helped Cut Independent Worker Uninsured Rate Nearly in Half, Yet Many Remain Without Health Coverage Due to Perceived Unaffordability
Dec 6, 2023 11:26AM VAST Data Closes Series E Funding Round, Nearly Triples Valuation to $9.1 Billion
Dec 6, 2023 08:05AM VAST Data eyes IPO after valuation surges to $9.1 billion in latest fund raise
Dec 5, 2023 10:00AM New Report Reveals that 83% of Companies are Prioritizing Product Integrations in 2024
Dec 5, 2023 09:00AM SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform
Dec 4, 2023 08:01AM Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
Nov 29, 2023 10:00AM Smartcar and Uber Partner to Accelerate the Transition to Electric by Removing Range Anxiety for Drivers
Nov 28, 2023 07:00AM Second Front Systems raises $40 million, led by NEA, to speed delivery of commercial software to global public sector
Nov 17, 2023 12:39PM Form SC 13D Korro Bio, Inc. Filed by: New Enterprise Associates 17, L.P.
Nov 16, 2023 10:00AM Care.com and Stride Team Up to Provide Caregivers Access to Health Insurance and Other Benefits
Nov 16, 2023 09:00AM Stride Health Partners with Shipt to Offer Shoppers and Drivers Access to Affordable Health Insurance During Open Enrollment
Nov 15, 2023 08:00AM MBX Biosciences to Participate in Piper Sandler 35th Annual Healthcare Conference
Nov 14, 2023 08:15AM Revelle Aesthetics Receives First International Clearance in Australia for its Avéli® Cellulite Device
Nov 13, 2023 09:00AM Myna Snacks Launches to Bring Health, Flavor, and Fun to Snacking in the Digital Age
Nov 9, 2023 02:15PM Aigen's $12M Series A Unleashes True-Solar Agriculture Robots
Nov 8, 2023 08:30PM LXA Raises US$10M in Seed Funding Round Led by NEA
Nov 7, 2023 09:25PM Form 3 Korro Bio, Inc. For: Nov 03 Filed by: New Enterprise Associates 17, L.P.
Nov 6, 2023 11:29AM AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
Nov 6, 2023 08:00AM Timescale Launches Dynamic PostgreSQL, the Cost-Effective Alternative to Serverless and Peak-Allocation Pay Models
Nov 1, 2023 08:00AM MBX Biosciences Announces Appointment of Michelle Graham as Chief Human Resources Officer
Oct 31, 2023 08:00AM MBX Biosciences to Participate in Stifel 2023 Healthcare Conference
Oct 27, 2023 09:00AM Stride Health Kicks Off 2024 ACA Open Enrollment with New Plan Selection Experience and New Partners
Oct 24, 2023 09:00AM Insurtech startup QuoteWell comes out of stealth, raised over $20M in Series A funding led by NEA
Oct 24, 2023 02:00AM AviadoBio Announces Presentation of Promising Preclinical Safety and Biodistribution Data of its Gene Therapy Candidate AVB-101 for FTD-GRN at the Annual European Society of Gene and Cell Therapy Cong
Oct 19, 2023 12:20PM Transfix Closes $40M Series F Funding Round Led by New Enterprise Associates and G Squared
Oct 18, 2023 08:00AM Waymark Secures Additional $42M to Scale Tech-Enabled, Community-Based Care for Primary Care Providers and People Enrolled in Medicaid
Oct 16, 2023 04:00PM MBX Biosciences Presents Positive Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Oct 13, 2023 04:18PM Form SC 13D/A SYNLOGIC, INC. Filed by: New Enterprise Associates 14, L.P.
Oct 12, 2023 09:00AM Mojo Vision Closes Successful New Series A Funding Round with $43.5M to Drive Micro-LED Development and Commercialization
Oct 10, 2023 09:54AM Pair Eyewear Announces $75M Series C Funding Round As It Touts Revenue Growth And Enhanced Automated U.S. Manufacturing
Oct 10, 2023 07:00AM AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
Oct 9, 2023 08:00AM MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Oct 3, 2023 08:00AM MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Sep 28, 2023 05:20PM Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
Sep 27, 2023 10:02AM Non-Alcoholic Retailer Boisson Announces New CEO; Receives New Funding From Convivialité Ventures and Connect Ventures
Sep 19, 2023 06:45AM Bright Health Group (BHG) Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down
Sep 19, 2023 06:45AM Bright Health Group Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down
Sep 13, 2023 08:30AM Hunt Scanlon Media to Host Private Equity and Venture Capital Recruiting Conference
Sep 11, 2023 08:00AM MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109, a Long-Acting Parathyroid Hormone Peptide Prodrug, in Healthy Adults
Sep 6, 2023 10:48AM SafeBase Acquires Fellow Y Combinator-Backed Stacksi to Fuel Its Vision for Zero-friction Security Assessments
Sep 6, 2023 08:00AM OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
Sep 5, 2023 08:07AM Revelle Aesthetics™ Brings Cellulite Education to the Forefront in Celebration of National Cellulite Day
Aug 31, 2023 01:30AM Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty cer
Aug 30, 2023 09:00AM Zeal Capital Partners Welcomes Former New Enterprise Associates Healthcare Investor, Emily Zhen, as Principal
Aug 29, 2023 08:00AM MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
Aug 23, 2023 09:00AM Modyfi launches full public beta for AI design platform, announces $7M in seed funding led by NEA
Aug 21, 2023 02:34PM Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
Aug 15, 2023 10:00AM Reimagined TechCrunch Disrupt 2023 Features New Stages and Return of Expanded Startup Battlefield Competition
Aug 7, 2023 08:00AM MBX Biosciences Announces U.S. FDA Clearance of IND Application for MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
View More Recent Stories View Older Stories